These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25807130)

  • 1. Liposomal topical capsaicin in post-herpetic neuralgia: a safety pilot study.
    Teixeira MJ; Menezes LM; Silva V; Galhardoni R; Sasson J; Okada M; Duarte KP; Yeng LT; Andrade DC
    Arq Neuropsiquiatr; 2015 Mar; 73(3):237-40. PubMed ID: 25807130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.
    Backonja MM; Malan TP; Vanhove GF; Tobias JK;
    Pain Med; 2010 Apr; 11(4):600-8. PubMed ID: 20113411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).
    Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M
    Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effective pain relief of post-herpetic neuralgia with capsaicin patch].
    Andersen HH; Sand C; Elberling J
    Ugeskr Laeger; 2016 Feb; 178(5):V10150846. PubMed ID: 26857302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
    Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
    Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
    Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
    BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia.
    Watson CP; Tyler KL; Bickers DR; Millikan LE; Smith S; Coleman E
    Clin Ther; 1993; 15(3):510-26. PubMed ID: 8364943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo.
    Kosuwon W; Sirichatiwapee W; Wisanuyotin T; Jeeravipoolvarn P; Laupattarakasem W
    J Med Assoc Thai; 2010 Oct; 93(10):1188-95. PubMed ID: 20973322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
    Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
    Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Irving GA; Backonja MM; Dunteman E; Blonsky ER; Vanhove GF; Lu SP; Tobias J;
    Pain Med; 2011 Jan; 12(1):99-109. PubMed ID: 21087403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.
    Irving G; Backonja M; Rauck R; Webster LR; Tobias JK; Vanhove GF
    Clin J Pain; 2012 Feb; 28(2):101-7. PubMed ID: 21753727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial.
    Kulkantrakorn K; Lorsuwansiri C; Meesawatsom P
    Pain Pract; 2013 Jul; 13(6):497-503. PubMed ID: 23228119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Webster LR; Malan TP; Tuchman MM; Mollen MD; Tobias JK; Vanhove GF
    J Pain; 2010 Oct; 11(10):972-82. PubMed ID: 20655809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous prostaglandin E1 on pain and body temperature in patients with post-herpetic neuralgia.
    Kanai A; Wang G; Hoshi K; Okamoto H
    Pain Med; 2010 Apr; 11(4):609-16. PubMed ID: 20345617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.
    Kulkantrakorn K; Chomjit A; Sithinamsuwan P; Tharavanij T; Suwankanoknark J; Napunnaphat P
    J Clin Neurosci; 2019 Apr; 62():174-179. PubMed ID: 30472337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia.
    Makharita MY; Amr YM; El-Bayoumy Y
    Pain Physician; 2012; 15(6):467-74. PubMed ID: 23159962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.